Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction MY Chan, JL Sun, LK Newby, LK Shaw, M Lin, ED Peterson, RM Califf, ... Circulation 119 (24), 3110-3117, 2009 | 337 | 2009 |
The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell Metabolism 35 (3), 414-428. e3, 2023 | 321 | 2023 |
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy PA Gurbel, D Erlinge, EM Ohman, B Neely, M Neely, SG Goodman, ... Jama 308 (17), 1785-1794, 2012 | 272 | 2012 |
Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium DA Gorog, RF Storey, PA Gurbel, US Tantry, JS Berger, MY Chan, ... Nature Reviews Cardiology 19 (7), 475-495, 2022 | 267 | 2022 |
Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention CH Lee, R Sethi, R Li, HH Ho, T Hein, MH Jim, G Loo, CY Koo, XF Gao, ... Circulation 133 (21), 2008-2017, 2016 | 237 | 2016 |
The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ... Thrombosis and haemostasis 121 (04), 422-432, 2021 | 211 | 2021 |
Coronavirus-induced myocarditis: a meta-summary of cases JSY Ho, CH Sia, MYY Chan, W Lin, RCC Wong Heart & Lung 49 (6), 681-685, 2020 | 181 | 2020 |
An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023 | 179 | 2023 |
Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ... The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022 | 177 | 2022 |
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching … S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ... JACC: Cardiovascular Interventions 8 (1 Part B), 189-197, 2015 | 175 | 2015 |
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease MY Chan, MG Cohen, CK Dyke, SK Myles, LG Aberle, M Lin, J Walder, ... Circulation 117 (22), 2865-2874, 2008 | 166 | 2008 |
Hypercoagulable states in cardiovascular disease MY Chan, F Andreotti, RC Becker Circulation 118 (22), 2286-2297, 2008 | 162 | 2008 |
Acute coronary syndrome in the Asia-Pacific region MY Chan, X Du, D Eccleston, C Ma, PP Mohanan, M Ogita, KG Shyu, ... international Journal of Cardiology 202, 861-869, 2016 | 152 | 2016 |
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 B Chong, J Jayabaskaran, G Kong, YH Chan, YH Chin, R Goh, S Kannan, ... EClinicalMedicine 57, 2023 | 150 | 2023 |
Severe obstructive sleep apnea and outcomes following myocardial infarction CH Lee, SM Khoo, MY Chan, HB Wong, AF Low, QH Phua, AM Richards, ... Journal of Clinical Sleep Medicine 7 (6), 616-621, 2011 | 146 | 2011 |
Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous … H Bulluck, MHH Chan, V Paradies, RL Yellon, HH Ho, MY Chan, ... Journal of Cardiovascular Magnetic Resonance 20 (1), 72, 2018 | 139 | 2018 |
A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor MY Chan, CP Rusconi, JH Alexander, RM Tonkens, RA Harrington, ... Journal of Thrombosis and Haemostasis 6 (5), 789-796, 2008 | 136 | 2008 |
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention MG Cohen, DA Purdy, JS Rossi, LR Grinfeld, SK Myles, LH Aberle, ... Circulation 122 (6), 614-622, 2010 | 107 | 2010 |
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study X Lu, Z Liu, Q Cui, F Liu, J Li, X Niu, C Shen, D Hu, K Huang, J Chen, ... European heart journal 43 (18), 1702-1711, 2022 | 102 | 2022 |
Obesity in COVID-19: a systematic review and meta-analysis JSY Ho, DI Fernando, MY Chan, CH Sia Ann Acad Med Singap 49 (12), 996-1008, 2020 | 98 | 2020 |